SCHEDULE 13D

Company

BioLineRx Ltd.

Filed

February 27, 2012

Accession Number

0001019056-12-000254

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →